Child node | Parent node | Validation | Attribution | LP Weights |
---|---|---|---|---|
FGF-9(K + 1) | (\( \overline{\mathrm{MIP}-2} \) *(k)&\( \overline{\mathrm{Vegf}-\mathrm{A}} \) (k)) || (MIP-2(k) & VEGF-A(k)) || (\( \overline{\mathrm{MIP}-2} \) (k) &Lymphotactin(k)) | Lymphotactin [64]: | IS | (89.6, 87, − 82) |
GM-CSF(K + 1) | \( \overline{\mathrm{MCP}-1} \) (K) || SCF(K) | SCF: String | Output | (2.75, −3.23) |
IFN- γ (K + 1) | MIP-2(k) || \( \overline{\mathrm{Vegf}-\mathrm{A}} \) (k) | VEGF-A: String | IS | (34, − 31.7) |
IP-10(K + 1) | VEGF-A(K) | IS | 121 | |
IL-1α(K + 1) | N/A | Input [71]: | Input | N/A |
IL-2(K + 1) | MCP-3(K) | String | IS | 92.7 |
IL-3(K + 1) | MCP-3(K) | Output | 41.9 | |
IL-4(K + 1) | MCP-1(K) | Output | 151 | |
IL-6(K + 1) | Lymphotactin(K) | [77] | Output | 58.7 |
IL-7(K + 1) | IL-1α(K) & MCP-5* (K) | IL-1α: [78] | Output | (−0.9, − 1) |
IL-10(K + 1) | VEGF-A(K) | [79] | IS | − 296 |
IL-12p70(K + 1) | Lymphotactin(K) | KEGG | Output | 0.557 |
IL-17A(K + 1) | MCP-3(K) | Output | (.34) | |
Lympho-tactin(K + 1) | IL-1α (K) & MCP-5 (K) | [82] | IS | (192, − 159) |
MIP-1ϐ(K + 1) | IL-1α(K) & MCP-1(K)) | MCP-1: String, | IS | (− 6490, 6650) |
MIP-2(K + 1) | MCP-3(K)& MCP-5(K) | MCP-3 [87]: MCP-5: String [87], | IS | (816, − 1160) |
MCP-1(K + 1) | \( \overline{\mathrm{IL}-2} \) (K) & \( \overline{\mathrm{MIP}-1\upbeta} \) MIP-1ϐ(K) | IS | (− 6150, − 6520) | |
MCP-3(K + 1) | IFN- γ (K) &MCP-1(K) | MCP-1: String [92], | IS | (−15,900, 16,800) |
MCP-5(K + 1) | SCF(K) || \( \overline{\mathrm{VEGF}-\mathrm{A}} \) (K) | SCF [93]: VEGF-A: KEGG | IS | (1300, − 1140) |
OSM(K + 1) | MCP-1(K) | Output | 1.11 | |
SCF(K + 1) | FGF-9(K)* & IL-10(K) | IS | (12,700, − 14,400) | |
TIMP-1(K + 1) | Lymphotactin*(K) | Not validated | Output | 1.19 |
TNF-α(K + 1) | IL-2(K) | Output | −0.188 | |
VEGF-A(K + 1) | MCP-5(K) & SCF(K) | MCP-5:String | IS | (−13,400, 13,300) |